封面
市场调查报告书
商品编码
1836311

经导管栓塞及封堵装置市场(依产品、国家及地区)-2025 年至 2032 年全球产业分析、市场规模、市场占有率及预测

Transcatheter Embolization and Occlusion Devices Market, By Product, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年经导管栓塞和封堵装置市场规模价值 54.932 亿美元,2025 年至 2032 年的复合年增长率为 7.80%。

经导管栓塞和封堵装置能够利用导管将合成栓子经由特定身体部位插入或送入体内。经导管栓塞是一种微创技术,用于介入放射学,以阻断流向癌性肿瘤的血流。为了探索多种靶向肿瘤的策略,合成材料偶尔会用于包裹化疗药物,以同时阻断血液供应并产生细胞毒性。

经导管栓塞及封堵装置市场-市场动态

对微创技术的需求不断增加,推动了市场的成长。

微创技术日益增长的需求预计将在不久的将来推动经导管栓塞和封锁装置市场的成长。微创手术利用小切口或自然体孔进入并治疗内部结构、器官或组织,从而减少对患者身体的创伤。经导管栓塞和封堵装置在这些技术中发挥重要作用,具有许多优势,例如创伤小、恢復时间短、治疗针对性强、疼痛轻、併发症风险低以及可进行门诊手术。例如,美国一家专门从事微创医疗产品的科技公司 Intuitive Surgical Inc. 报告称,2022 年使用达文西手术系统进行的手术约有 1,875,000 例,比 2021 年的约 1,594,000 例增长 18%。因此,对微创技术日益增长的需求是经导管栓塞和封堵装置市场的主要驱动力。

经导管栓塞及封堵装置市场-細項分析:

全球经导管栓塞和闭塞装置市场根据产品和地区进行细分。

市场由两大产品类别构成:弹簧圈和非弹簧圈。非弹簧圈产品凭藉其在各种临床应用中的多功能性和有效性,将在2025年占据市场主导地位,并占据最高收入份额。非弹簧圈设备,例如液体栓塞剂和颗粒栓塞产品,可提供精确且可控制的栓塞,是治疗复杂血管疾病的理想选择。它们能够轻鬆应对复杂的解剖结构,并以最少的併发症提供卓越的治疗效果,赢得了介入放射科医生和外科医生的高度讚誉。这种日益增长的偏好也巩固了该领域的市场主导地位。

经导管栓塞及封堵装置市场-地理洞察

2025年,北美经导管栓塞和封堵装置市场将占据全球市场主导地位。这得益于介入放射学 (IR) 手术的日益普及。子宫肌瘤栓塞术 (UFE) 是一种微创的 IR 手术,作为有症状子宫肌瘤的治疗选择,正日益受到青睐。这种非手术方法可以加快患者康復,并减少子宫切除术的需求。患者对微创治疗的需求不断增长,加上医疗保健提供者的认知度不断提高,推动了栓塞装置的使用,并扩大了这些创新解决方案的市场。这些装置用于治疗心房颤动和静脉曲张。

预计亚太地区经导管栓塞和封堵装置市场将在2025年至2032年间实现最快成长。该地区癌症发生率的不断上升推动了对这些装置的需求。它们为多种癌症提供了有效的治疗选择,包括肝癌和肺癌,而栓塞是肿瘤管理的​​重要组成部分。医疗保健投资的不断增加,透过扩大先进医疗技术的可近性和改善医疗保健基础设施,正在推动市场成长。癌症发生率的上升和医疗保健能力的不断提升,预计将推动整个地区的经导管栓塞和封锁装置产业向前发展。

经导管栓塞及封堵装置市场-竞争格局:

经导管栓塞和封堵装置市场竞争激烈,雅培、波士顿科学公司、泰尔茂公司、美敦力和DePuy Synthes(强生公司)占据领先地位。这些公司提供各种创新设备,例如栓塞线圈、血管栓塞和液体栓塞剂,这些设备通常与先进的成像和导管导航系统整合。竞争围绕着技术创新、小型化以及提高肿瘤、神经病学和周边血管手术的安全性和有效性。

目录

第 1 章:经导管栓塞与封堵装置市场概述

  • 研究范围
  • 市场估计年限

第二章:执行摘要

  • 市场片段
    • 经导管栓塞及封堵装置市场(依产品)
    • 经导管栓塞和封堵装置市场(按国家/地区)
    • 经导管栓塞及封堵装置市场(按地区)
  • 竞争洞察

第三章:经导管栓塞和封堵装置的主要市场趋势

  • 经导管栓塞及封堵装置市场驱动因素
    • 市场驱动因素的影响分析
  • 经导管栓塞及封堵装置市场限制
    • 市场限制的影响分析
  • 经导管栓塞及封堵装置的市场机会
  • 经导管栓塞及封堵装置市场未来趋势

第四章:经导管栓塞及封堵装置产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章:经导管栓塞与封堵装置市场:地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章:经导管栓塞及封堵装置市场格局

  • 经导管栓塞及封堵装置市占率分析(2024年)
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章:经导管栓塞和封堵装置市场 - 按产品

  • 概述
    • 按产品细分市场占有率分析
    • 线圈
      • 可推式线圈
      • 可拆卸弹簧圈
    • 非线圈
      • 流量转向装置
      • 栓塞颗粒
      • 液态栓塞剂
      • 其他栓塞及封堵装置
      • 配件

第 8 章:经导管栓塞和封堵装置市场 - 按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美经导管栓塞和封堵装置主要製造商
    • 北美市场规模及预测(按国家/地区)
    • 北美市场规模及预测(按产品)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲经导管栓塞及封堵装置主要製造商
    • 欧洲市场规模及预测(按国家/地区)
    • 欧洲市场规模及预测(按产品)
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区(APAC)
    • 概述
    • 亚太地区经导管栓塞及封堵装置主要製造商
    • 亚太地区市场规模及预测(依国家)
    • 亚太地区市场规模及预测(依产品)
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲(LATAM)
    • 概述
    • 拉丁美洲经导管栓塞和封堵装置主要製造商
    • 拉丁美洲市场规模及预测(按国家/地区)
    • 拉丁美洲市场规模及预测(按产品)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲(MEA)
    • 概述
    • 中东和非洲经导管栓塞和封堵装置主要製造商
    • MEA 市场规模及预测(依国家/地区)
    • MEA 市场规模及预测(依产品)
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第九章:主要供应商分析-经导管栓塞及封堵装置产业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Abbott
    • Boston Scientific Corporation
    • Terumo Corporation
    • Medtronic
    • DePuy Synthes (Johnson & Johnson)
    • Stryker
    • Cordis
    • Pfizer Inc.
    • Sirtex SIR-Spheres Pty Ltd.
    • Nordion (Canada) Inc.
    • Others

第 10 章:360 度分析师视角

第 11 章:附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5615

Transcatheter Embolization and Occlusion Devices Market size was valued at US$ 5,493.20 Million in 2024, expanding at a CAGR of 7.80% from 2025 to 2032.

Transcatheter embolization and occlusion devices enable the insertion or passage of a synthetic embolus into the body via a specific body part while utilizing a catheter. Transcatheter embolization is a minimally invasive technique used in interventional radiology to stop blood flow to cancerous tumors. To identify many strategies for targeting tumors, synthetic materials are occasionally used to coat chemotherapeutic medications in order to perform simultaneous acts of blood supply blocking and cytotoxicity.

Transcatheter Embolization and Occlusion Devices Market- Market Dynamics

Increasing demand for minimally invasive techniques fuels market growth.

The growing demand for minimally invasive techniques is expected to drive the growth of the transcatheter embolization and occlusion device market in the near future. Minimally invasive surgeries use small incisions or natural body openings to access and treat internal structures, organs, or tissues, reducing trauma to the patient's body. Transcatheter embolization and occlusion devices play an important role in these techniques, providing numerous benefits such as reduced invasiveness, shorter recovery times, targeted treatment, less pain, lower complication risks, and the possibility of outpatient procedures. For instance, Intuitive Surgical Inc., a US-based technology corporation specializing in minimally invasive medical products, reported that approximately 1,875,000 surgical procedures were performed using da Vinci surgical systems in 2022, up 18% from about 1,594,000 in 2021. As a result, the growing demand for minimally invasive techniques is a major driver in the transcatheter embolization and occlusion devices market.

Transcatheter Embolization and Occlusion Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2025-2032)

Based on Product segmentation, non-coil was predicted to show maximum market share in the year 2024

On the basis of region, North American was the leading revenue generator in 2024

Transcatheter Embolisation and Occlusion Devices Market- Segmentation Analysis:

The Global Transcatheter Embolisation and Occlusion Devices Market is segmented on the basis of Product and Region.

Two product-based categories comprise the market: Coil and Non-Coil. The non-coil segment will dominate the market with the highest revenue share in 2025, owing to its versatility and effectiveness in a variety of clinical applications. Non-coil devices, such as liquid embolic agents and particle embolization products, provide precise and controlled embolization, which is ideal for treating complex vascular conditions. Their ability to navigate difficult anatomy and provide superior results with minimal complications has earned them high praise among interventional radiologists and surgeons. This growing preference has contributed to the segment's market dominance.

Transcatheter Embolization and Occlusion Devices Market- Geographical Insights

The North American transcatheter embolization and occlusion device market will dominate the global market in 2025. This is due to the increased use of interventional radiology (IR) procedures. Uterine Fibroid Embolization (UFE), a minimally invasive IR procedure, is increasingly popular as a treatment option for symptomatic uterine fibroids. This nonsurgical approach allows for faster recovery and reduces the need for hysterectomy. Rising patient demand for less invasive treatments, combined with increased awareness among healthcare providers, is driving up the use of embolization devices and expanding the market for these innovative solutions. These devices are used to treat atrial fibrillation and varicose veins.

The Asia Pacific transcatheter embolization and occlusion device market is expected to grow the fastest between 2025 and 2032. The growing prevalence of cancer in the region is driving up demand for these devices. They provide effective treatment options for a variety of cancers, including liver and lung cancer, where embolization is an important part of tumor management. Rising healthcare investments are fueling market growth by increasing access to advanced medical technologies and improving healthcare infrastructure. This combination of rising cancer rates and expanding healthcare capabilities is expected to propel the transcatheter embolization and occlusion devices industry forward across the region.

Transcatheter Embolization and Occlusion Devices Market- Competitive Landscape:

The Transcatheter Embolization and Occlusion Devices Market is highly competitive, with Abbott, Boston Scientific Corporation, Terumo Corporation, Medtronic, and DePuy Synthes (Johnson & Johnson) leading the way. These companies provide a diverse range of innovative devices, such as embolization coils, vascular plugs, and liquid embolic agents, which are frequently integrated with advanced imaging and catheter navigation systems. The competition revolves around technological innovation, miniaturization, and increased safety and efficacy for oncology, neurology, and peripheral vascular procedures.

Recent Developments:

In January 2025, Stryker has agreed to acquire Inari Medical for USD 4.9 billion, expanding its presence in venous thromboembolism care.

In July 2025, Teleflex acquired BIOTRONIK's vascular intervention business for EUR 760 million, expanding its portfolio to include drug-coated balloons and the Freesolve resorbable scaffold.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic
  • DePuy Synthes (Johnson & Johnson)
  • Stryker
  • Cordis
  • Pfizer Inc.
  • Sirtex SIR-Spheres Pty Ltd.
  • Nordion (Canada) Inc.
  • Others

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Coil
  • Pushable Coils
  • Detachable Coils
  • Non Coil
  • Flow Diverting Devices
  • Embolization Particles
  • Liquid Embolics
  • Other Embolization and Occlusion Devices
  • Accessories

GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Transcatheter Embolization And Occlusion Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Transcatheter Embolization And Occlusion Devices Market Snippet by Product
    • 2.1.2. Transcatheter Embolization And Occlusion Devices Market Snippet by Country
    • 2.1.3. Transcatheter Embolization And Occlusion Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Transcatheter Embolization And Occlusion Devices Key Market Trends

  • 3.1. Transcatheter Embolization And Occlusion Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Transcatheter Embolization And Occlusion Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Transcatheter Embolization And Occlusion Devices Market Opportunities
  • 3.4. Transcatheter Embolization And Occlusion Devices Market Future Trends

4. Transcatheter Embolization And Occlusion Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Transcatheter Embolization And Occlusion Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Transcatheter Embolization And Occlusion Devices Market Landscape

  • 6.1. Transcatheter Embolization And Occlusion Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Transcatheter Embolization And Occlusion Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Coil
      • 7.1.2.1. Pushable Coils
      • 7.1.2.2. Detachable Coils
    • 7.1.3. Non Coil
      • 7.1.3.1. Flow Diverting Devices
      • 7.1.3.2. Embolization Particles
      • 7.1.3.3. Liquid Embolics
      • 7.1.3.4. Other Embolization and Occlusion Devices
      • 7.1.3.5. Accessories

8. Transcatheter Embolization And Occlusion Devices Market- By Geography

  • 8.1. Introduction
    • 8.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in North America
    • 8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.2.5. U.S.
      • 8.2.5.1. Overview
      • 8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.2.5.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.2.6. Canada
      • 8.2.6.1. Overview
      • 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.2.6.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Europe
    • 8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.5. Germany
      • 8.3.5.1. Overview
      • 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.5.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.6. UK
      • 8.3.6.1. Overview
      • 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.6.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.7. France
      • 8.3.7.1. Overview
      • 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.8. Italy
      • 8.3.8.1. Overview
      • 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.9. Spain
      • 8.3.9.1. Overview
      • 8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.9.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.10. The Netherlands
      • 8.3.10.1. Overview
      • 8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.10.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.11. Sweden
      • 8.3.11.1. Overview
      • 8.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.11.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.12. Russia
      • 8.3.12.1. Overview
      • 8.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.13. Poland
      • 8.3.13.1. Overview
      • 8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.13.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.3.14. Rest of Europe
      • 8.3.14.1. Overview
      • 8.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Asia Pacific
    • 8.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.5. China
      • 8.4.5.1. Overview
      • 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.5.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.6. India
      • 8.4.6.1. Overview
      • 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.7. Japan
      • 8.4.7.1. Overview
      • 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.7.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.8. South Korea
      • 8.4.8.1. Overview
      • 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.9. Australia
      • 8.4.9.1. Overview
      • 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.9.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.10. Indonesia
      • 8.4.10.1. Overview
      • 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.10.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.11. Thailand
      • 8.4.11.1. Overview
      • 8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.12. Philippines
      • 8.4.12.1. Overview
      • 8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.12.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.4.13. Rest of APAC
      • 8.4.13.1. Overview
      • 8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.4.13.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 8.5. Latin America (LATAM)
    • 8.5.1. Overview
    • 8.5.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Latin America
    • 8.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.5. Brazil
      • 8.5.5.1. Overview
      • 8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.5.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.6. Mexico
      • 8.5.6.1. Overview
      • 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.6.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.7. Argentina
      • 8.5.7.1. Overview
      • 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.7.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.8. Colombia
      • 8.5.8.1. Overview
      • 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.8.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.5.9. Rest of LATAM
      • 8.5.9.1. Overview
      • 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.5.9.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  • 8.6. Middle East and Africa (MEA)
    • 8.6.1. Overview
    • 8.6.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Middle East and Africa
    • 8.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 8.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.5. Saudi Arabia
      • 8.6.5.1. Overview
      • 8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.5.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.6. UAE
      • 8.6.6.1. Overview
      • 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.6.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.7. Israel
      • 8.6.7.1. Overview
      • 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.7.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.8. Turkey
      • 8.6.8.1. Overview
      • 8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.8.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.9. Algeria
      • 8.6.9.1. Overview
      • 8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.9.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.10. Egypt
      • 8.6.10.1. Overview
      • 8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.10.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 8.6.11. Rest of MEA
      • 8.6.11.1. Overview
      • 8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 8.6.11.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)

9. Key Vendor Analysis- Transcatheter Embolization And Occlusion Devices Industry

  • 9.1. Competitive Benchmarking
    • 9.1.1. Competitive Dashboard
    • 9.1.2. Competitive Positioning
  • 9.2. Company Profiles
    • 9.2.1. Abbott
    • 9.2.2. Boston Scientific Corporation
    • 9.2.3. Terumo Corporation
    • 9.2.4. Medtronic
    • 9.2.5. DePuy Synthes (Johnson & Johnson)
    • 9.2.6. Stryker
    • 9.2.7. Cordis
    • 9.2.8. Pfizer Inc.
    • 9.2.9. Sirtex SIR-Spheres Pty Ltd.
    • 9.2.10. Nordion (Canada) Inc.
    • 9.2.11. Others

10. 360 Degree AnalystView

11. Appendix

  • 11.1. Research Methodology
  • 11.2. References
  • 11.3. Abbreviations
  • 11.4. Disclaimer
  • 11.5. Contact Us